A newsletter has been launched to support the EXPRESS study (Optimising Exome PREnatal Sequencing Services) and the R21 Prenatal Exome Service.
The study, a three-year NIHR HS&DR funded project, has been set up to evaluate the implementation of prenatal exome sequencing now that the service is being offered as part of national mainstream care.
You can download the September Issue of the newsletter here!
To find out more about the research, and to subscribe to future updates, email the team at firstname.lastname@example.org.
For more information about the clinical service contact either the North Thames GLH Testing Laboratory at email@example.com or Central and South GLH Testing Laboratory at firstname.lastname@example.org.